CA2617830A1 - Direct molecular cloning of a modified eukaryotic cytoplasmic dna virus genome - Google Patents

Direct molecular cloning of a modified eukaryotic cytoplasmic dna virus genome Download PDF

Info

Publication number
CA2617830A1
CA2617830A1 CA002617830A CA2617830A CA2617830A1 CA 2617830 A1 CA2617830 A1 CA 2617830A1 CA 002617830 A CA002617830 A CA 002617830A CA 2617830 A CA2617830 A CA 2617830A CA 2617830 A1 CA2617830 A1 CA 2617830A1
Authority
CA
Canada
Prior art keywords
molecular cloning
chordopoxvirus
plasmid
modified
virus genome
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002617830A
Other languages
French (fr)
Other versions
CA2617830C (en
Inventor
Friedrich Dorner
Friedrich Scheiflinger
Falko Gunter Falkner
Michael Pfleiderer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter Healthcare SA
Original Assignee
Baxter Healthcare S.A.
Friedrich Dorner
Friedrich Scheiflinger
Falko Gunter Falkner
Michael Pfleiderer
Immuno Aktiengesellschaft
Baxter Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/750,080 external-priority patent/US5445953A/en
Application filed by Baxter Healthcare S.A., Friedrich Dorner, Friedrich Scheiflinger, Falko Gunter Falkner, Michael Pfleiderer, Immuno Aktiengesellschaft, Baxter Aktiengesellschaft filed Critical Baxter Healthcare S.A.
Priority claimed from CA002558864A external-priority patent/CA2558864C/en
Publication of CA2617830A1 publication Critical patent/CA2617830A1/en
Application granted granted Critical
Publication of CA2617830C publication Critical patent/CA2617830C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The invention provides a plasmid for producing a modified chordopoxvirus, wherein the plasmid comprises a segment of a chordopoxvirus genome that comprises a thymidine kinase gene of said chordopoxvirus, wherein said thymidine kinase gene has been modified to prevent expression of active thymidine kinase, wherein said plasmid is as shown in Figure 4.2 and is selected from the group of plasmids: pHindJ-2 comprising the sequence of SEQ. ID. NO.
4, and pHindJ-3 comprising the sequence of SEQ. ID. NO. 5.

Claims (2)

1. A plasmid for producing a modified chordopoxvirus, wherein the plasmid comprises a segment of a chordopoxvirus genome that comprises a thymidine kinase gene of said chordopoxvirus, wherein said thymidine kinase gene has been modified to prevent expression of active thymidine kinase, wherein said plasmid is as shown in Figure 4.2 and is selected from the group of plasmids: pHindJ-2 comprising the sequence of SEQ. ID. NO. 4, and pHindJ-3 comprising the sequence of SEQ. ID. NO. 5.
2. Use of a plasmid as defined in Claim 1 for producing a modified chordopoxvirus by direct molecular cloning.
CA2617830A 1991-08-26 1992-08-25 Direct molecular cloning of a modified eukaryotic cytoplasmic dna virus genome Expired - Fee Related CA2617830C (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US07/750,080 US5445953A (en) 1991-08-26 1991-08-26 Direct molecular cloning of a modified poxvirus genome
US07/750,080 1991-08-26
US91473892A 1992-07-20 1992-07-20
US07/914,738 1992-07-20
CA002558864A CA2558864C (en) 1991-08-26 1992-08-25 Direct molecular cloning of a modified eukaryotic cytoplasmic dna virus genome

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002558864A Division CA2558864C (en) 1991-08-26 1992-08-25 Direct molecular cloning of a modified eukaryotic cytoplasmic dna virus genome

Publications (2)

Publication Number Publication Date
CA2617830A1 true CA2617830A1 (en) 1993-02-27
CA2617830C CA2617830C (en) 2010-04-06

Family

ID=39103181

Family Applications (3)

Application Number Title Priority Date Filing Date
CA2617830A Expired - Fee Related CA2617830C (en) 1991-08-26 1992-08-25 Direct molecular cloning of a modified eukaryotic cytoplasmic dna virus genome
CA002616717A Abandoned CA2616717A1 (en) 1991-08-26 1992-08-25 Direct molecular cloning of a modified eukaryotic cytoplasmic dna virus genome
CA002616698A Expired - Fee Related CA2616698C (en) 1991-08-26 1992-08-25 Direct molecular cloning of a modified eukaryotic cytoplasmic dna virus genome

Family Applications After (2)

Application Number Title Priority Date Filing Date
CA002616717A Abandoned CA2616717A1 (en) 1991-08-26 1992-08-25 Direct molecular cloning of a modified eukaryotic cytoplasmic dna virus genome
CA002616698A Expired - Fee Related CA2616698C (en) 1991-08-26 1992-08-25 Direct molecular cloning of a modified eukaryotic cytoplasmic dna virus genome

Country Status (1)

Country Link
CA (3) CA2617830C (en)

Also Published As

Publication number Publication date
CA2616698C (en) 2009-03-17
CA2616717A1 (en) 1993-02-27
CA2617830C (en) 2010-04-06
CA2616698A1 (en) 1993-02-27

Similar Documents

Publication Publication Date Title
Sacerdot et al. Sequence of a 1.26‐kb DNA fragment containing the structural gene for E. coli initiation factor IF3: presence of an AUU initiator codon.
AU692163B2 (en) Retroviral vector for the transfer and expression of genes for therapeutical purposes in eucaryotic cells
CA2154023A1 (en) Recombinant infectious non-segmented negative strand rna virus
AU7335296A (en) Recombinant sendai virus
CA2128589A1 (en) Selection marker gene free recombinant strains: a method for obtaining them and the use of these strains
CA2230033A1 (en) Production of infectious respiratory syncytial virus from cloned nucleotide sequences
MX9702212A (en) Novel pesticidal proteins and strains.
AU8067698A (en) Chimeric vectors comprising a phage packaging site and a portion derived from a genome of a eukaryotic virus
CA2075515A1 (en) Method for synthesizing stable single-stranded cdna in eucaryotes by means of a bacterial retron, products and uses therefor
TR200401186T4 (en) Artificial chromosome structures containing nucleic acid sequences capable of directing the formation of a recombinant RNA-virus.
CA2215328A1 (en) Novel human cytomegalovirus dna sequences
IL144467A0 (en) Expression of alkaline phosphatase in yeast
AU6839898A (en) Vaccine composition for preventing or treating c hepatitis
EP1209228A3 (en) Environmental stress responsive promoter
NZ508439A (en) Novel endometriosis-associated gene
EP1803813A3 (en) An environmental stress-responsive promoter and an gene encoding environmental stress-responsive transcriptional factor
CA2095109A1 (en) Process for production of exogenous gene or its product in plant cells
AU4835696A (en) Amplifying sequences, vectors comprising these sequences and their uses in compositions for the expression of nucleotide sequences in transfected cells, therapeutic and vaccine applications.
CA2617830A1 (en) Direct molecular cloning of a modified eukaryotic cytoplasmic dna virus genome
CA2681966A1 (en) Baculovirus expression system
AU8447098A (en) Endogenetic retroviral sequences, associated with autoimmune diseases or with pregnancy disorders
EP0683238A3 (en) A process for the cloning of DNA
JP2002542828A5 (en)
AU4712497A (en) Retroviral vectors
WO1997003345A3 (en) Detection and quantification of human herpesvirus 7 by enzymic amplification dna virus dna

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed